ILSI-Biomed is a young yet "fast growing" and keyed-up conference, and this year's edition was the most successful and probably the most fruitful yet.
The vaccine market is a huge and growing market valued at €16 billion in 2008 with an annual growth of about 15 to 18%. The vaccine market could account for more than €25 billion by 2012.
Switzerland has become an attractive place that is highly active in the life sciences and in particular in hosting biotech companies.